Pholtex Bronchostop relieves any cough, whether dry, tickly, or wet, chesty, with mucous. Pholtex Bronchostop relieves a cough with minimal known side effects. The brand is non-drowsy, alcohol-, lactose- and GMO-free.
Pholtex Bronchostop is the only product on the South African market that contains the natural ingredients marshmallow root dry extract and thyme herb extract, which work collaboratively to relieve any cough.
Complementary action
Unlike antitussives that act centrally to suppress the cough centre of the brain, marshmallow dry root extract (a demulcent) acts locally to coat the throat, relieve cough irritation and reduce the urge to cough. This means that marshmallow root dry extract (a demulcent) and thyme herb extract (an expectorant) can safely be administered together as their effects do not antagonise each other, but rather are complementary.
Pholtex Bronchostop offers a product for the whole family from children of 1 years old. It is available in a syrup format for use at home or work, and in a convenient pastille format (soft lozenge) for cough relief on the go, without the hassle of carrying a bottle.
Bronchostop will be available in pharmacies in April 2020.
Scheduling Status: S0 Proprietary name (and dosage form): Pholtex Bronchostop® Cough Syrup. Composition: Each 5 ml syrup contains: 39 mg Thyme herb extract and 277 mg Marshmallow root dry extract. Pharmacological Classification: Complementary Medicine: Discipline Specific Traditional Claims D33.6 Western Herbal Medicine. Scheduling Status: S0 Proprietary name (and dosage form): Pholtex Bronchostop® Cough Pastilles. Composition: Each pastille contains: 51.1 mg Thyme herb extract and 4.5 mg Marshmallow root dry extract. Pharmacological Classification: Complementary Medicine: Discipline Specific Traditional Claims D33.6 Western Herbal Medicine. Proprietary name (and dosage form): Pholtex Bronchostop® Children’s Cough Syrup. Composition: Each 5 ml syrup contains: 48 mg Marshmallow root dry extract and 250 mg Honey. These unregistered medicines have not been evaluated by the SAHPRA for its quality, safety or intended use. The claims made in this material is for medical information and educational purposes only. For full prescribing information, refer to the individual professional information or instructions for use. Further information is available on request from iNova Pharmaceuticals. Name and business address of applicant: iNova Pharmaceuticals (Pty) Limited. Co. Reg. No. 1952/001640/07, 15e Riley Road, Bedfordview. Tel. No. 011 087 0000. www.inovapharma.co.za. IN3536/19.
